Physician profile
Jeffrey Thomas Abildgaard
NPI 1528388584
$74,048.99
in general payments reported to CMS, 2019-2025
14 companies · $48K in 2025
The $48K reported for 2025 was more than what 95% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,326 · 2020: $1,201 · 2021: $3,654 · 2022: $1,888 · 2023: $152 · 2024: $18K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $56K · Travel and Lodging: $7,332 · Food and Beverage: $2,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $55,978.10 |
| Travel and Lodging | $7,332.22 |
| Food and Beverage | $2,669.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Miach Orthopaedics, INC. | $65,143.44 | 2024-2025 | |
| Impactortho, INC. | $3,248.54 | 2021-2024 | |
| Arthrex, INC. | $2,619.41 | 2020-2022 | |
| Goode Surgical INC | $2,325.62 | 2019-2020 | |
| Orthofix Medical, INC. | $187.09 | 2020-2025 | Physio-Stim |
| Anika Therapeutics, INC. | $144.65 | 2025 | Integrity Implant |
| Depuy Synthes Sales INC. | $108.76 | 2020 | |
| Zimmer Biomet Holdings, INC. | $65.05 | 2020 | |
| Abbott Laboratories | $46.85 | 2021-2025 | Proclaim |
| Becton, Dickinson and Company | $45.34 | 2025 | Hemosphere |
| Vericel Corporation | $38.28 | 2022-2024 | Maci |
| Kowa Pharmaceuticals America, INC. | $35.82 | 2023 | Seglentis |
| Stryker Corporation | $23.98 | 2025 | Alphavent |
| Endo Pharmaceuticals INC. | $16.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Abildgaard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.